Company Name:Retrophin Inc.
CEO: Eric Dube

Sector: Healthcare

Exchange: NASDAQ Global Market

Country: USA

Description: Retrophin Inc is a pharmaceutical company based in the United States. Its drug candidates are targeted at serious rare diseases such as gallstones and bile acid synthesis disorders.


Key numbers

Market Capitalization:555876520
Shares Outstanding: 42958000
Float: 41755090.084
Next Earning Date:2020-02-25
TTm EPS: -2.9422
TTm Dividend Rate:
200 days moving average:17.82
50 days moving average: 11.88
One day percent Change: 14.92



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,